Cargando…

A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic

Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities invo...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, John E., Dumas, Bob A., McCarthy, Myles T., Dewitt, Barry D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457623/
https://www.ncbi.nlm.nih.gov/pubmed/32869042
http://dx.doi.org/10.1101/2020.08.23.20180349
_version_ 1783576031114821632
author McCarthy, John E.
Dumas, Bob A.
McCarthy, Myles T.
Dewitt, Barry D.
author_facet McCarthy, John E.
Dumas, Bob A.
McCarthy, Myles T.
Dewitt, Barry D.
author_sort McCarthy, John E.
collection PubMed
description Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities involving groups of people, in order to decide whether that activity is worth undertaking. We propose a deterministic linear model of SARS-CoV-2 infection probability that can produce estimates of relative risk for diverse activities, so long as those activities meet a list of assumptions, including that they do not last longer than one day. We show how the model can be used to inform decisions facing governments and industry, such as opening stadiums or flying on airplanes. We prove that the model is a good approximation of a more refined model in which we assume infections come from a series of independent risks. The linearity assumption makes interpreting and using the model straightforward, and we argue that it does so without significantly diminishing the reliability of the model.
format Online
Article
Text
id pubmed-7457623
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-74576232020-09-01 A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic McCarthy, John E. Dumas, Bob A. McCarthy, Myles T. Dewitt, Barry D. medRxiv Article Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities involving groups of people, in order to decide whether that activity is worth undertaking. We propose a deterministic linear model of SARS-CoV-2 infection probability that can produce estimates of relative risk for diverse activities, so long as those activities meet a list of assumptions, including that they do not last longer than one day. We show how the model can be used to inform decisions facing governments and industry, such as opening stadiums or flying on airplanes. We prove that the model is a good approximation of a more refined model in which we assume infections come from a series of independent risks. The linearity assumption makes interpreting and using the model straightforward, and we argue that it does so without significantly diminishing the reliability of the model. Cold Spring Harbor Laboratory 2020-08-25 /pmc/articles/PMC7457623/ /pubmed/32869042 http://dx.doi.org/10.1101/2020.08.23.20180349 Text en http://creativecommons.org/licenses/by-nc/4.0/It is made available under a CC-BY-NC 4.0 International license (http://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Article
McCarthy, John E.
Dumas, Bob A.
McCarthy, Myles T.
Dewitt, Barry D.
A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic
title A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic
title_full A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic
title_fullStr A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic
title_full_unstemmed A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic
title_short A deterministic linear infection model to inform Risk-Cost-Benefit Analysis of activities during the SARS-CoV-2 pandemic
title_sort deterministic linear infection model to inform risk-cost-benefit analysis of activities during the sars-cov-2 pandemic
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457623/
https://www.ncbi.nlm.nih.gov/pubmed/32869042
http://dx.doi.org/10.1101/2020.08.23.20180349
work_keys_str_mv AT mccarthyjohne adeterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic
AT dumasboba adeterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic
AT mccarthymylest adeterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic
AT dewittbarryd adeterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic
AT mccarthyjohne deterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic
AT dumasboba deterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic
AT mccarthymylest deterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic
AT dewittbarryd deterministiclinearinfectionmodeltoinformriskcostbenefitanalysisofactivitiesduringthesarscov2pandemic